About miniPCR
miniPCR is a Healthcare company based in Cambridge (United States) founded in 2013. PCR and electrophoresis instruments are developed for laboratory use. Its website minipcr.com draws about 62 thousand monthly visits. miniPCR offers products and services including miniPCR® thermal cyclers, blueGel™ electrophoresis, miniPCR® APP, and Bandit™ Electrophoresis Kit. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Instrument Systems. Its legal entity is AMPLYUS LLC. Its competitors include NeuMoDx, GenMark Diagnostics and Biomeme; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2013 in Cambridge, United States, the company focuses on biotechnology instruments. PCR thermal cyclers and electrophoresis systems are produced, with the miniPCR device designed as a portable thermal cycler programmable through a free app on smartphones, tablets, or PCs. Field operations are supported by its robust build. The blueGel system integrates electrophoresis and visualization functions for streamlined workflows.
- Investors
Products & Services of miniPCR
miniPCR offers a comprehensive portfolio of products and services, including miniPCR® thermal cyclers, blueGel™ electrophoresis, miniPCR® APP, and Bandit™ Electrophoresis Kit.
Devices for DNA amplification in research and education
System for visualizing DNA separation quickly
Application for controlling thermal cyclers remotely
Kits for electrophoresis experiments in classrooms
Apps and channels of miniPCR
its YouTube channel miniPCR bio has 16K subscribers and 30 videos.
Videos from miniPCR
The most watched videos on miniPCR's YouTube channel, miniPCR bio (16K subscribers). Click a video to play it here.
More on miniPCR bio.
Funding Insights of miniPCR
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of miniPCR with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2014 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in miniPCR
miniPCR has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MassChallenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage entrepreneurs are accelerated through MassChallenge's program. | masschallenge.org | Boston, United States |
Investor details for miniPCR
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of miniPCR
2 dated milestones of miniPCR across 1 years, from founding to its latest funding, stage changes and deals.
- Founded miniPCR is founded.
- Funding First funding round.
Competitors of miniPCR
miniPCR has 3 listed competitors in our database, 3 of them funded. They include NeuMoDx, GenMark Diagnostics and Biomeme.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neumodx.com | 2012 | Ann Arbor, United States | $66.04M | 125 | Developer of a platform for low cost molecular testing | |
| genmarkdx.com | 1993 | San Diego, United States | $8.56M | 797 | Instruments and test panels for multiplexed molecular diagnostics are provided. | |
| biomeme.com | 2013 | Philadelphia, United States | $6.2M | 202 | Smartphone-based DNA detection platform is developed for diagnostics. |
Detailed competitors of miniPCR
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of miniPCR
The website of miniPCR (minipcr.com) receives about 62.3K visits a month.
- Monthly visits62.3K
▲ 7.3% vs previous month
Websites whose visitors overlap most with miniPCR. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
theminione.com | theminione.com | 100% | #2,316,589 | – | |
| nippongenetics.eu | 89% | #997,372 | View details | ||
| smobio.com | 89% | #2,491,541 | View details | ||
dnabarcoding101.org | dnabarcoding101.org | 87% | #3,106,070 | – | |
geneticeducation.co.in | geneticeducation.co.in | 87% | #676,234 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 34 similar websites and full traffic analytics for miniPCR
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 34 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as miniPCR (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about miniPCR
miniPCR was founded in 2013 and raised its 1st funding round 1 year after it was founded.
miniPCR is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Founded in 2013 in Cambridge, United States, the company focuses on biotechnology instruments. PCR thermal cyclers and electrophoresis systems are produced, with the miniPCR device designed as a portable thermal cycler programmable through a free app on smartphones, tablets, or PCs. Field operations are supported by its robust build. The blueGel system integrates electrophoresis and visualization functions for streamlined workflows.
miniPCR's top competitors include GenMark Diagnostics, NeuMoDx and Biomeme.
miniPCR offers miniPCR® thermal cyclers, blueGel™ electrophoresis, miniPCR® APP, and Bandit™ Electrophoresis Kit.
miniPCR has 1 investor. Key investors include MassChallenge.
miniPCR operates through Amplyus Llc.